Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03571893 · ClinicalTrials.gov registry record · NA

Study of an International Commercial Program on Weight Loss and Health Outcomes

A NA study of Obesity and Weight Loss, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
373
Enrollment target
4
Study locations

NCT03571893: Completed NA study of Obesity and Weight Loss, sponsored by University of North Carolina, Chapel Hill.

NCT03571893 is a NA study of Obesity and Weight Loss that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 373 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (54% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03571893, a NA study of Obesity and Weight Loss, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
373 participants
Enrollment target
4
Study locations

Study Summary

This study is a randomized controlled trial (RCT) of the Weight Watchers (WW) Freestyle ® (Flex® in UK) weight loss program compared to a control group following a do-it-yourself (DIY) approach for 12 months. Participants in the United States, Canada and the UK (n=360 total) will be randomly assigned to either participate in the commercially available WW program in their local community or to follow their own approach for weight loss. This study will examine the impact of the WW program on weight, fitness levels, quality of life, health behaviors and other health outcomes in overweight and obese adults after 3 and 12 months.

Primary Outcome

Weight will be measured in kg on a digital scale

Interventions

  • BEHAVIORAL Weight Watchers Freestyle (Flex)
  • BEHAVIORAL DIY Personal Plan

Study Locations (4)

British Columbia

  • University of British Columbia-Okanagan - Kelowna
  • University of British Columbia-Vancouver - Vancouver

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Other

  • University of Leeds - Leeds

Trial Details

FieldValue
Enrollment Target 373 participants
Start Date 2018-06-19
Est. Completion 2019-11-04
Phase NA

What the finished NCT03571893 record still lists

NCT03571893 is an interventional study that assigns participants to a tested intervention. The registered 373 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (54% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Weight Watchers Freestyle (Flex) is the first listed.

NCT03571893 reports a single indexed study location in British Columbia, North Carolina, Other.

Frequently Asked Questions

What is clinical trial NCT03571893 about?

NCT03571893 is a clinical study titled "Study of an International Commercial Program on Weight Loss and Health Outcomes". This study is a randomized controlled trial (RCT) of the Weight Watchers (WW) Freestyle ® (Flex® in UK) weight loss program compared to a control group following a do-it-yourself (DIY) approach for 12 months. Participants in the United States, Canada and the UK (n=360 total) will be randomly assigne...

What is the current status of trial NCT03571893?

This trial is currently completed. It is a NA study. The enrollment target is 373 participants. The study started on 2018-06-19. Estimated completion is 2019-11-04.

What conditions does trial NCT03571893 study?

This clinical trial studies the following conditions: Obesity, Weight Loss, Diet Modification, Weight Change, Body.

What interventions are being tested in trial NCT03571893?

The interventions under investigation include: Weight Watchers Freestyle (Flex) (BEHAVIORAL), DIY Personal Plan (BEHAVIORAL).

Who is sponsoring clinical trial NCT03571893?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03571893 being conducted?

This trial has 4 study locations across North Carolina, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03571893's enrollment target sits among peer trials

373 178th of 1053 higher than 876 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07276750 · 373 participants · NA

    Coaching and Leadership in Autism Support Settings

  • NCT04801589 · 372 participants · Phase 3

    Goal-Directed Sedation in Mechanically Ventilated Infants and Children

  • NCT04879329 · 372 participants · Phase 2

    A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • NCT05318105 · 372 participants · NA

    Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03571893, the US trial registry maintained by the National Library of Medicine. NCT03571893 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.